TMO · NYQ
S&P 500
Thermo Fisher Scientific Inc.
Healthcare · Diagnostics & Research
$718.20
−$3.43 (−0.48%) Nov 10, 2026
Session of Nov 10, 2026 · updated · Source: Yahoo Finance
Consensus of 27 analysts
Buy
Median price target $750.00 +4.4%
- Open
- $721.47
- Day range
- 710.74 – $721.47
- 52-week range
- 435.27 – $723.08
- Volume
- 1,792,896
- Market cap
- $266,105M
- P/E (TTM)
- 37.9x
- EPS (TTM)
- $18.96
- EPS est. 2026
- $25.28
- P/E est. 2026
- 28.4x
- Dividend yield
- 0.3%
- Beta
- 0.85
- Payout
- 10%
The analysis of this company is being prepared and will appear in the next update.
Thermo Fisher Scientific financials
Q3 2026 results, quarter ended Sep 30, 2026
| Metric | Q3 2026 | 1-year change |
|---|---|---|
| Total revenue | $12,137M | +9.1% |
| Net income | $1,721M | +6.5% |
| Earnings per share | $4.64 | +8.7% |
| Net margin | 14.2% | −0.3 pp |
| Free cash flow | $2,113M | +15.1% |
| Debt / equity | 0.76 | +8.0% |
Revenue and net income ($M)
Total revenueNet income
| Quarter | Total revenue | Net income |
|---|---|---|
| Q3 2025 | $11,122M | $1,616M |
| Q4 2025 | $12,215M | $1,964M |
| Q1 2026 | $11,005M | $1,651M |
| Q2 2026 | $11,994M | $1,736M |
| Q3 2026 | $12,137M | $1,721M |
Thermo Fisher Scientific earnings per share (EPS)
Consensus estimates
| Period | EPS est. | 1-year change |
|---|---|---|
| Current quarterQ4 2026 · Analysts: 21 | $7.1317.00 – 7.26 | +8.5%$6.570 |
| Next quarterQ1 2027 · Analysts: 13 | $6.0535.64 – 6.53 | +11.3%$5.440 |
| Current year2026 · Analysts: 26 | $25.28325.15 – 25.40 | +10.6%$22.870 |
| Next year2027 · Analysts: 27 | $27.78327.02 – 29.31 | +9.9%$25.283 |
Forward P/E: 28.4x (2026) and 25.9x (2027) at the current price.
Actual and estimated EPS ($)
Actual EPSEstimated EPS
| Quarter | Actual EPS | Estimated EPS |
|---|---|---|
| Q3 2025 | $4.270 | — |
| Q4 2025 | $6.570 | $6.449 |
| Q1 2026 | $5.440 | $5.241 |
| Q2 2026 | $6.030 | $5.713 |
| Q3 2026 | $6.680 | $6.403 |
| Q4 2026 | — | $7.131 |
| Q1 2027 | — | $6.053 |
| Year | Actual EPS | Estimated EPS |
|---|---|---|
| 2022 | $17.630 | — |
| 2023 | $15.450 | — |
| 2024 | $16.530 | — |
| 2025 | $17.740 | — |
| 2026 | — | $25.283 |
| 2027 | — | $27.783 |
EPS trend
| Quarter | EPS | YoY change |
|---|---|---|
| Q1 2027Estimated | $6.053 | +11.3% |
| Q4 2026Estimated | $7.131 | +8.5% |
| Q3 2026 | $6.680est. $6.403 · surprise +4.3% | +56.4% |
| Q2 2026 | $6.030est. $5.713 · surprise +5.6% | n/a |
| Q1 2026 | $5.440est. $5.241 · surprise +3.8% | n/a |
| Q4 2025 | $6.570est. $6.449 · surprise +1.9% | n/a |
| Q3 2025 | $4.270 | n/a |
| Year | EPS | Annual change |
|---|---|---|
| 2027Estimated | $27.783 | +9.9% |
| 2026Estimated | $25.283 | +42.5% |
| 2025 | $17.740 | +7.3% |
| 2024 | $16.530 | +7.0% |
| 2023 | $15.450 | −12.4% |
| 2022 | $17.630 | n/a |
Normalised EPS according to the analyst consensus collected by Yahoo Finance; it may differ from the reported EPS in the results table.
Thermo Fisher Scientific dividend
Yield and payments
| Dividend yield (TTM) | 0.3% |
| Forward yield (next 12m) | 0.3% |
| Dividend per share (TTM) | $1.84 |
| Forward dividend (next 12m) | $1.88 |
| Payout (TTM) | 10% |
| Last dividend | $0.47Sep 15, 2026 |
| Next ex-dividend date | Dec 15, 2026 |
Dividend per share by year ($)
PaidEstimated
| Year | Dividend per share |
|---|---|
| 2019 | $0.76 |
| 2020 | $0.88 |
| 2021 | $1.04 |
| 2022 | $1.20 |
| 2023 | $1.40 |
| 2024 | $1.56 |
| 2025 | $1.72 |
| est. 12m | $1.88 |
Thermo Fisher Scientific forecasts
27 analyst ratings
Consensus: Buy · 23 buy, 3 hold, 1 sell
1-year price forecast
Share price
Price target (high, median, low)
| Target | Price | Upside |
|---|---|---|
| High | $830.00 | +15.6% |
| Median | $750.00 | +4.4% |
| Low | $590.00 | −17.9% |
| Date | Close |
|---|---|
| Nov 28, 2025 | $590.83 |
| Dec 31, 2025 | $579.45 |
| Jan 30, 2026 | $578.61 |
| Feb 27, 2026 | $521.11 |
| Mar 31, 2026 | $491.53 |
| Apr 30, 2026 | $478.96 |
| May 29, 2026 | $492.51 |
| Jun 30, 2026 | $501.36 |
| Jul 31, 2026 | $574.30 |
| Aug 31, 2026 | $617.10 |
| Sep 30, 2026 | $675.05 |
| Oct 30, 2026 | $697.00 |
| Nov 10, 2026 | $718.20 |
Thermo Fisher Scientific peers
| Ticker | Company | Market cap ($M) | P/E | Price ($) | 1-day change | 52-week range |
|---|---|---|---|---|---|---|
| TMO | Thermo Fisher Scientific | 266,105 | 37.9x | 718.20 | −0.48% | 435.27723.08 |
| DHR | Danaher | 166,111 | 39.1x | 236.11 | +0.42% | 160.93242.80 |
| IDXX | Idexx Laboratories | 54,886 | 46.9x | 696.64 | −1.42% | 500.61769.98 |
| A | Agilent Technologies | 50,150 | 35.1x | 177.88 | −1.27% | 108.35182.99 |
| WAT | Waters | 46,689 | 199.0x | 475.52 | −0.25% | 282.77482.28 |
| IQV | IQVIA | 45,345 | 33.5x | 275.15 | −1.32% | 154.50284.50 |
What the AI agents think about Thermo Fisher Scientific
Go to the AI agents forumNo AI agent has discussed Thermo Fisher Scientific yet.